Month: May 2024

Precision Value and Health Unveils New Identity: Precision AQ

  • Precision Value and Health rebrand signals fuller integration of services to better facilitate access to life-changing medicine
  • As part of rebrand, International Europe-based companies Makara Health and Across Health will be changing names to align their brand with Precision AQ
  • The rebrand comes at the same time as the establishment of a new International matrix structure bringing together the teams based outside the US to work together more closely to meet the needs of International clients

London, 21 May 2024 – Precision Value and Health today announced that the company is rebranding as Precision AQ. The new name is the culmination of years of strategic development and integration to create a single company with unrivaled scale, services and strengths to help life sciences companies navigate the complexities surrounding patient access to life-changing therapies across the product lifecycle.

Combined services under the new brand include: investor relations & external communications, global pricing and market access strategy, evidence generation, brand promotion, medical education, omnichannel solutions, learning and development, PR and patient insights & support.

The rebrand will include recent UK-based International acquisition, Makara Health Communications, and Belgium-based omnichannel strategy and product specialists, Across Health, also acquired by Precision three years ago.

Unifying nine organisations under one name and brand signals a shift to a more streamlined and comprehensive experience for Precision AQ clients making it easier to access the company’s considerable global expertise and services.

“Precision AQ exists for one reason: To empower access to life-changing medicine for all,” said Precision AQ President, Doug Fulling. “We are stronger together, combining the strength of life-science experts, advisors, and creators, all working towards the same goal: changing the blueprint for access.”

The name itself, which stands for Precision Access Quotient, reflects the organisation’s approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in a medicine’s journey from bench to bedside that the organisation feels is often overlooked.

International offering

Alongside the rebrand, Precision AQ recently appointed Louise Sharp as EVP, General Manager of its International team, with a view to facilitating greater collaboration across the services lines that sit outside the US, and signaling to International clients the considerable expertise and experience within this region.

Louise, shares her excitement about her new role:

“Moving hearts and minds is our business, and we believe this takes equal parts science and humanity. My role will focus on using our patient-first mission to ensure the organisation’s blueprint for access is tailored to the specific needs of our International audiences. I am thrilled to be taking on this newly created role and look forward to continuing to augment and grow Precision AQ’s International footprint.”

Data Driven Precision, Unified Access

According to Fulling, the company has built an unrivaled organisation by bringing together the best experts in the business to provide the most comprehensive view of the healthcare journey, overcoming challenges with data-driven precision, while always grounding solutions in empathy.

Precision AQ partners have unfettered access to data, experience and knowledge from any point in the therapy journey to help guide decisions based on real-world experience of what’s to come. Precision AQ’s offerings range from economics outcomes research in the U.S., to key opinion leader (KOL) and digital opinion leader (DOL) mapping and omnichannel customer insights across the world.  Combined, these capabilities can break down knowledge and process silos that create unforeseen roadblocks in bringing therapies to market.

“Our teams range from deeply analytical to highly creative, giving partners comprehensive access to over 100 types of specialists that, combined, provide a unique and comprehensive perspective across the entire commercialisation continuum,” said Fulling. “No matter how few or how many of our diverse specialist teams you engage with, you get the added value of our collective expertise across all disciplines to help guide you through what’s to come.”

About Precision AQ

Precision AQ, formerly known as Precision Value & Health, helps life sciences companies navigate the complexities of access, across a product’s lifecycle, to get more therapies to the patients that need them. The company comprises life-science experts, advisors, and creators working to change the blueprint for access with data-driven precision, grounded in empathy. Precision AQ unifies several organizations under one name and brand, including PRECISIONadvisors (global pricing and market access strategy), PRECISIONeffect (healthcare communications and marketing), PRECISIONheor (evidence generation and strategy), PRECISIONscientia (medical communications), PRECISIONvalue (managed markets marketing), PRECISIONxtract (data-driven analytics and insights), Stern Investor Relations (investor relations and external communications), Makara Health (International brand, medical education, L&D, PR and patient insights services) and Across Health (Omnichannel solutions and strategy).  Visit: